相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Primary endpoints for irritable bowel syndrome trials: A review of performance of endpoints
Michael Camilleri et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Adequate relief in IBS treatment trials:: Corrections to errors stated by whitehead et al.
Allen W. Mangel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Irritable bowel syndrome
N. J. Talley
INTERNAL MEDICINE JOURNAL (2006)
Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective
J. Tack et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Reports of satisfactory relief by IBS patients receiving usual medical care are confounded by baseline symptom severity and do not accurately reflect symptom improvement
William E. Whitehead et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Functional bowel disorders
George F. Longstreth et al.
GASTROENTEROLOGY (2006)
Design of treatment trials for functional gastrointestinal disorders
E. Jan Irvine et al.
GASTROENTEROLOGY (2006)
A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation
J Tack et al.
GUT (2005)
Irritable bowel syndrome: Toward an understanding of severity
A Lembo et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2005)
A prospective assessment of bowel habit in irritable bowel syndrome in women: Defining an alternator
DA Drossman et al.
GASTROENTEROLOGY (2005)
Diagnostic yield of alarm features in irritable bowel syndrome and functional dyspepsia
J Hammer et al.
GUT (2004)
Outcome of patients with obscure gastrointestinal bleeding after capsule endoscopy: Report of 100 consecutive cases
M Pennazio et al.
GASTROENTEROLOGY (2004)
A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome
H Nyhlin et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2004)
The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC
AE De Jong et al.
GASTROENTEROLOGY (2004)
Validation of irritable bowel syndrome global improvement scale - An integrated symptom end point for assessing treatment efficacy
S Gordon et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome
J Kellow et al.
GUT (2003)
A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome
M Camilleri et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial
M Camilleri et al.
LANCET (2000)